Autologous Cell Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024


#143277

152pages

Transparency

$ 5795

In Stock

Global Autologous Cell Therapy Market: Overview

This report provides in-depth region wise and country wise analysis of the autologous cell therapy market. Stakeholders of this report include manufacturers of cell therapy products, raw material suppliers, cancer drug processing companies, and new players planning to enter the market.

The report provides qualitative and quantitative analysis of the global autologous cell therapy market. Qualitative analysis comprises market dynamics, trends, product overview, and country-level market information. Quantitative analysis includes major players with their reported revenue, market size, and forecast for the global autologous cell therapy market in major countries globally such as the U.S., Canada, Germany, France, United Kingdom, Switzerland, Spain, Japan, China, Brazil, Mexico, South Africa and Saudi Arabia. Market revenue is provided in terms of US$ Mn from 2014 to 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 for all the segments, considering 2015 as the base year. The executive summary of the report provides a snapshot of the autologous cell therapy with information on leading segments, country wise market information with respect to the market size, growth rate (CAGR %), and growth factors. Moreover, the report also includes pipeline analysis (phase I & II) of the autologous cell therapy market on basis of disease conditions.

Global Autologous Cell Therapy Market: Drivers and Trends

The market overview section comprises impact factors such as drivers, restraints, and opportunities for the global autologous cell therapy market. These factors would aid the stakeholders in establishing a strong foothold in the global autologous cell therapy market. Furthermore, the market overview section comprises key industry events, product overview, market attractiveness analysis and emerging trend in the autologous cell therapy market. The market attractiveness analysis provides a graphical view comparing the growth and market dynamics in various segments and country wise to identify the most attractive market.

Global Autologous Cell Therapy Market: Segmentation

The autologous cell therapy market has been segmented as source, application, end-user and geography. Based on source, the market has been segmented into bone marrow, epidermis and others. Likewise, on basis of application the market has been categorized into neurology, orthopedic, cancer, wound healing, CVD, autoimmune, and others. Hospitals, ambulatory centers and research centers are included into the market by end-user.

Global Autologous Cell Therapy Market: Regional Outlook

Geographically, the autologous cell therapy market has been categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Moreover, analysis for the major countries comprising U.S. Canada, Germany, U.K., France, Switzerland, Spain, Japan, China, Brazil, Mexico, South Africa and Saudi Arabia have also been provided in the report. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the autologous cell therapy market in various regions has been provided in this section.

This report also includes various ups and downs about particular country or geography that has impacted the overall market globally. The report provides a detailed outline/blueprint of the autologous cell therapy market globally that will assist new companies in establishing their presence and market players in expanding their market share in the market.

Key Players Mentioned in the Report are:

The report concludes with the company profile section which includes company overview, financial overview, SWOT analysis, product portfolio, business strategies and recent developments for market players. The major players that are profiled in the report include BIOTIME, INC., BrainStorm Cell Therapeutics, Caladrius Biosciences, Inc., Vericel Corporation, Pharmicell Co., Inc., TiGenix N.V., Fibrocell Science, Inc. and Opexa Therapeutics, Inc. among others.

The global autologous cell therapy market has been segmented into:

Global Autologous Cell Therapy Market, by Source

  • Bone Marrow
  • Epidermis
  • Others

Global Autologous Cell Therapy Market, by Application

  • Neurology
  • Orthopedic
  • Cancer
  • Wound Healing
  • CVD
  • Autoimmune
  • Others

Global Autologous Cell Therapy Market, by End User

  • Hospitals
  • Ambulatory Centers
  • Research Centers

Global Autologous Cell Therapy Market, by Geography

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Switzerland
  • Spain
  • Rest of Europe
  • Asia Pacific (APAC)
  • Japan
  • China
  • India
  • Rest of APAC
  • Latin America (LATAM)
  • Brazil
  • Mexico
  • Rest of LATAM
  • Middle East & Africa (MEA)
  • South Africa
  • Saudi Arabia
  • Rest of MEA

Table of Content

1. Preface
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Objectives
1.4. Key Questions Answered

2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Acronyms Used
2.3. Research Methodology

3. Executive Summary
3.1. Global Autologous Cell Therapy Market Snapshot
3.2. Market Opportunity Map

4. Market Overview
4.1. Product Overview
4.2. Key Industry Events
4.3. Death Rate of Leukemia, by Country
4.4. Death Rate of Cancer, by Country

5. Market Dynamics
5.1. Drivers and Restraints Snapshot Analysis
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Opportunity Analysis
5.6. Pipeline Analysis (Phase I & II)

6. Global Autologous Cell Therapy Market Analysis, by Source
6.1. Key Findings
6.2. Introduction
6.3. Bone Marrow
6.4. Epidermis
6.5. Others
6.6. Key Trends
6.7. Market Attractiveness Analysis

7. Global Autologous Cell Therapy Market Analysis, by Application
7.1. Key Findings
7.2. Introduction
7.3. Neurology
7.4. Orthopedic
7.5. Cancer
7.6. Wound Healing
7.7. CVD
7.8. Autoimmune
7.9. Others
7.10. Key Trends
7.11. Market Attractiveness Analysis

8. Global Autologous Cell Therapy Market Analysis, by End-user
8.1. Key Findings
8.2. Introduction
8.3. Hospitals
8.4. Ambulatory Centers 
8.5. Research Centers
8.6. Key Trend Analysis
8.7. Market Attractiveness Analysis

9. Global Autologous Cell Therapy Market Analysis, by Region
9.1. North America
9.2. Europe
9.3. Asia Pacific
9.4. Latin America
9.5. Middle East & Africa
9.6. Market Attractiveness Analysis

10. North America Autologous Cell Therapy Market Analysis
10.1. North America Autologous Cell Therapy Market Size Forecast, By Country, 2016-2024
10.2. North America Autologous Cell Therapy Market Size Forecast, By Source, 2016-2024
10.3. North America Autologous Cell Therapy Market Size Forecast, By Application, 2016-2024
10.4. North America Autologous Cell Therapy Market Size Forecast, By End-user, 2016-2024
10.5. North America Autologous Cell Therapy Market Attractiveness Analysis, 2016-2024

11. Europe Autologous Cell Therapy Market Analysis
11.1. Europe Autologous Cell Therapy Market Size Forecast, By Country, 2016-2024
11.2. Europe Autologous Cell Therapy Market Size Forecast, By Source, 2016-2024
11.3. Europe Autologous Cell Therapy Market Size Forecast, By Application, 2016-2024
11.4. Europe Autologous Cell Therapy Market Size Forecast, By End-user, 2016-2024
11.5. Europe Autologous Cell Therapy Market Attractiveness Analysis, 2016-2024

12. Asia Pacific Autologous Cell Therapy Market Analysis
12.1. Asia Pacific Autologous Cell Therapy Market Size Forecast, By Country, 2016-2024
12.2. Asia Pacific Autologous Cell Therapy Market Size Forecast, By Source, 2016-2024
12.3. Asia Pacific Autologous Cell Therapy Market Size Forecast, By Application, 2016-2024
12.4. Asia Pacific Autologous Cell Therapy Market Size Forecast, By End-user, 2016-2024
12.5. Asia Pacific Autologous Cell Therapy Market Attractiveness Analysis, 2016-2024

13. Latin America Autologous Cell Therapy Market Analysis
13.1. Latin America Autologous Cell Therapy Market Size Forecast, By Country, 2016-2024
13.2. Latin America Autologous Cell Therapy Market Size Forecast, By Source, 2016-2024 
13.3. Latin America Autologous Cell Therapy Market Size Forecast, By Application, 2016-2024
13.4. Latin America Autologous Cell Therapy Market Size Forecast, By End-user, 2016-2024
13.5. Latin America Autologous Cell Therapy Market Attractiveness Analysis, 2016-2024

14. Middle East & Africa Autologous Cell Therapy Market Analysis
14.1. Middle East & Africa Autologous Cell Therapy Market Size Forecast, By Country, 2016-2024
14.2. Middle East & Africa Autologous Cell Therapy Market Size Forecast, By Source, 2016-2024
14.3. Middle East & Africa Autologous Cell Therapy Market Size Forecast, By Application, 2016-2024
14.4. Middle East & Africa Autologous Cell Therapy Market Size Forecast, By End-user, 2016-2024
14.5. Middle East & Africa Autologous Cell Therapy Market Attractiveness Analysis, 2016-2024

15. Competitive Landscape
15.1. Competition Matrix
15.1. Pharmicell Co., Inc.
15.2. Fibrocell Science, Inc. 
15.3. Vericel Corporation
15.4. BioTime, Inc.

16. Company Profiles
16.1. BioTime, Inc.
16.1.1. Company Details
16.1.2. Company Description
16.1.3. Business Overview
16.1.4. SWOT Analysis
16.1.5. Financial Analysis
16.1.6. Strategic Overview
16.2. BrainStorm Cell Therapeutics
16.2.1. Company Details
16.2.2. Company Description
16.2.3. Business Overview
16.2.4. SWOT Analysis
16.2.5. Financial Analysis
16.2.6. Strategic Overview
16.3. Caladrius Biosciences, Inc.
16.3.1. Company Details
16.3.2. Company Description
16.3.3. Business Overview
16.3.4. SWOT Analysis
16.3.5. Financial Analysis
16.3.6. Strategic Overview
16.4. Fibrocell Science, Inc.
16.4.1. Company Details
16.4.2. Company Description
16.4.3. Business Overview
16.4.4. SWOT Analysis
16.4.5. Financial Analysis
16.4.6. Strategic Overview
16.5. Opexa Therapeutics, Inc.
16.5.1. Company Details
16.5.2. Company Description
16.5.3. Business Overview
16.5.4. SWOT Analysis
16.5.5. Financial Analysis
16.5.6. Strategic Overview
16.6. Pharmicell Co., Inc.
16.6.1. Company Details
16.6.2. Company Description
16.6.3. Business Overview
16.6.4. SWOT Analysis
16.6.5. Financial Analysis
16.6.6. Strategic Overview
16.7. Regeneus Ltd.
16.7.1. Company Details
16.7.2. Company Description
16.7.3. Business Overview
16.7.4. SWOT Analysis
16.7.5. Financial Analysis
16.7.6. Strategic Overview
16.8. TiGenix NV
16.8.1. Company Details
16.8.2. Company Description
16.8.3. Business Overview
16.8.4. SWOT Analysis
16.8.5. Financial Analysis
16.8.6. Strategic Overview
16.9. TxCell SA
16.9.1. Company Details
16.9.2. Company Description
16.9.3. Business Overview
16.9.4. SWOT Analysis
16.9.5. Financial Analysis
16.9.6. Strategic Overview
16.10. U.S. Stem Cell, Inc.
16.10.1. Company Details
16.10.2. Company Description
16.10.3. Business Overview
16.10.4. SWOT Analysis
16.10.5. Financial Analysis
16.10.6. Strategic Overview
16.11. Vericel Corporation
16.11.1. Company Details
16.11.2. Company Description
16.11.3. Business Overview
16.11.4. SWOT Analysis
16.11.5. Financial Analysis
16.11.6. Strategic Overview

List of Tables

TABLE 1 Global Autologous Cell Therapy Market Size (US$ Mn) Forecast, by Source, 2016–2024
TABLE 2 Global Autologous Cell Therapy Market Size (US$ Mn) Forecast, by Application, 2016–2024
TABLE 3 Global Autologous Cell Therapy Market Size (US$ Mn) & Forecast, by End-user, 2016–2024
TABLE 4 Global Autologous Cell Therapy Market Size (US$ Mn) Forecast, by Region, 2016–2024
TABLE 5 North America Autologous Cell Therapy Market Size (US$ Mn) Forecast, by Country, 2016–2024
TABLE 6 North America Autologous Cell Therapy Market Size (US$ Mn) Forecast, by Source, 2016–2024
TABLE 7 North America Autologous Cell Therapy Market Size (US$) Forecast, by Application, 2016–2024
TABLE 8 North America Autologous Cell Therapy Market Size (US$ Mn) Forecast, by End-user, 2016–2024
TABLE 9 Europe Autologous Cell Therapy Market Size (US$ Mn) Forecast, by Country, 2016–2024
TABLE 10 Europe Autologous Cell Therapy Market Size (US$ Mn) Forecast, by Source, 2016–2024
TABLE 11 Europe Autologous Cell Therapy Market Size (US$ Mn) Forecast, by Application, 2016–2024
TABLE 12 Europe Autologous Cell Therapy Market Size (US$ Mn) Forecast, by End-user, 2016–2024
TABLE 13 Asia Pacific Autologous Cell Therapy Market Size (US$ Mn) Forecast, by Country, 2016–2024
TABLE 14 Asia Pacific  Autologous Cell Therapy Market Size (US$ Mn) Forecast, by Source, 2016–2024
TABLE 15 Asia Pacific Autologous Cell Therapy Market Size (US$ Mn) Forecast, by Application, 2016–2024
TABLE 16 Asia Pacific Autologous Cell Therapy Market Size (US$ Mn) Forecast, by End-user, 2016–2024
TABLE 17 Latin America Autologous Cell Therapy Market Size (US$ Mn) Forecast, by Country, 2016–2024
TABLE 18 Latin America Autologous Cell Therapy Market Size (US$ Mn) Forecast, by Source, 2016–2024
TABLE 19 Latin America Autologous Cell Therapy Market Size (US$ Mn) Forecast, by Application, 2016–2024
TABLE 20 Latin America Autologous Cell Therapy Market Size (US$ Mn) Forecast, by End-user, 2016–2024
TABLE 21 MEA Autologous Cell Therapy Market Size (US$ Mn) Forecast, by Country, 2016–2024
TABLE 22 MEA Autologous Cell Therapy Market Size (US$ Mn) Forecast, by Source, 2016–2024
TABLE 23 MEA Autologous Cell Therapy Market Size (US$ Mn) Forecast, by Application, 2016–2024
TABLE 24 MEA Autologous Cell Therapy Market Size (US$ Mn) Forecast, by End-user, 2016–2024

List of Figures

FIG. 1 Global Autologous Cell Therapy Market Value Share Analysis, by Source, 2015 and 2024
FIG. 2 Global Bone Marrow Market Size Forecast (US$ Mn), 2016–2024
FIG. 3 Global Epidermis Market Size Forecast (US$ Mn), 2016–2024
FIG. 4 Global Others Market Size Forecast (US$ Mn), 2016–2024
FIG. 5 Autologous Cell Therapy Market Attractiveness Analysis, by Source
FIG. 6 Global Autologous Cell Therapy Market Value Share Analysis, by Application, 2015 and 202
FIG. 7 Global Bone Marrow Market Size Forecast (US$ Mn), 2016–2024
FIG. 8 Global Epidermis Market Size Forecast (US$ Mn), 2016–2024
FIG. 9 Global Bone Marrow Market Size Forecast (US$ Mn), 2016–2024
FIG. 10 Global Epidermis Market Size Forecast (US$ Mn), 2016–2024
FIG. 11 Global Bone Marrow Market Size Forecast (US$ Mn), 2016–2024
FIG. 12 Global Epidermis Market Size Forecast (US$ Mn), 2016–2024
FIG. 13 Global Others Market Size Forecast (US$ Mn), 2016–2024
FIG. 14 Global Autologous Cell Therapy Market Attractiveness Analysis, by Application
FIG. 15 Global Autologous Cell Therapy Market Value Share Analysis, by End-user, 2015 and 2024
FIG. 16 Global Hospitals Market Size Forecast (US$ Mn), 2016–2024
FIG. 17 Global Ambulatory Centers Market Size Forecast (US$ Mn), 2016–2024
FIG. 18 Global Research Centers Market Revenue (US$ Mn), 2014–2024
FIG. 19 Global Autologous Cell Therapy Market Attractiveness Analysis, by End-user
FIG. 20 North America Autologous Cell Therapy Market Size (US$ Mn) Forecast, 2016–2024
FIG. 21 Europe Autologous Cell Therapy Market Size (US$ Mn) Forecast, 2016–2024
FIG. 22 Asia Pacific Autologous Cell Therapy Market Size (US$ Mn) Forecast, 2016–2024
FIG. 23 Latin America Autologous Cell Therapy Market Size (US$ Mn) Forecast, 2016–2024
FIG. 24 MEA Autologous Cell Therapy Market Size (US$ Mn) Forecast, 2016–2024
FIG. 25 Global Autologous Cell Therapy Market Attractiveness Analysis, by Region
FIG. 26 U.S. Autologous Cell Therapy Market Size (US$ Mn) Forecast, 2016–2024
FIG. 27 Canada Autologous Cell Therapy Market Size (US$ Mn) Forecast, 2016–2024
FIG. 28 North America Autologous Cell Therapy Market Attractiveness Analysis, by Country
FIG. 29 North America Autologous Cell Therapy Market Attractiveness Analysis, by Source
FIG. 30 North America Autologous Cell Therapy Market Attractiveness Analysis, by Applicat
FIG. 31 North America Autologous Cell Therapy Market Attractiveness Analysis, by End-user
FIG. 32 Germany Autologous Cell Therapy Market Size (US$ Mn) Forecast, 2016–2024
FIG. 33 U.K. Autologous Cell Therapy Market Size (US$ Mn) Forecast, 2016–2024
FIG. 34 France Autologous Cell Therapy Market Size (US$ Mn) Forecast, 2016–20
FIG. 35 Spain Autologous Cell Therapy Market Size (US$ Mn) Forecast, 2016–2024
FIG. 36 Switzerland Autologous Cell Therapy Market Size (US$ Mn) Forecast, 2016–2024
FIG. 37 Rest of Europe Autologous Cell Therapy Market Size (US$ Mn) Forecast, 2016–2024
FIG. 38 Europe Autologous Cell Therapy Market Attractiveness Analysis, by Country
FIG. 39 Europe Autologous Cell Therapy Market Attractiveness Analysis, Source
FIG. 40 Europe Autologous Cell Therapy Market Attractiveness Analysis, by Applicatio
FIG. 41 Europe Autologous Cell Therapy Market Attractiveness Analysis, by End-user
FIG. 42 Japan Autologous Cell Therapy Market Size (US$ Mn) Forecast, 2016–2024
FIG. 43 China Autologous Cell Therapy Market Size (US$ Mn) Forecast, 2016
FIG. 44 India Autologous Cell Therapy Market Size (US$ Mn) Forecast, 2016–2024
FIG. 45 Rest of APAC Autologous Cell Therapy Market Size (US$ Mn) Forecast, 
FIG. 46 2016–2024
FIG. 47 Asia Pacific Autologous Cell Therapy Market Attractiveness Analysis, by Country
FIG. 48 Asia Pacific Autologous Cell Therapy Market Attractiveness Analysis, by Source
FIG. 49 Asia Pacific Autologous Cell Therapy Market Attractiveness Analysis, by Application
FIG. 50 Asia Pacific Autologous Cell Therapy Market Attractiveness Analysis, by End-user
FIG. 51 Brazil Autologous Cell Therapy Market Size (US$ Mn) Forecast, 2016–202
FIG. 52 Mexico Autologous Cell Therapy Market Size (US$ Mn) Forecast, 2016–2024
FIG. 53 Rest of LATAM Autologous Cell Therapy Market Size (US$ Mn) Forecast, 2016–2024
FIG. 54 Latin America Autologous Cell Therapy Market Attractiveness Analysis, by Country
FIG. 55 Latin America Autologous Cell Therapy Market Attractiveness Analysis, by Source
FIG. 56 Latin America Autologous Cell Therapy Market Attractiveness Analysis, by Application
FIG. 57 Latin America Autologous Cell Therapy Market Attractiveness Analysis, by End-user
FIG. 58 South Africa Autologous Cell Therapy Market Size (US$ Mn) Forecast, 2016–2024
FIG. 59 Saudi Arabia Autologous Cell Therapy Market Size (US$ Mn) Forecast, 2016–2024
FIG. 60 Rest of MEA Autologous Cell Therapy Market Size (US$ Mn) Forecast, 2016–2024
FIG. 61 Middle East & Africa Autologous Cell Therapy Market Attractiveness Analysis, by Country
FIG. 62 Middle East & Africa Autologous Cell Therapy Market Attractiveness Analysis, by Source
FIG. 63 Middle East & Africa Autologous Cell Therapy Market Attractiveness Analysis, by Application